Carisma Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Carisma Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Carisma Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.1M, a 41.2% increase year-over-year.
  • Carisma Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$66.8M, a 18.2% increase year-over-year.
  • Carisma Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$88.7M, a 58% decline from 2022.
  • Carisma Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$56.2M, a 557% decline from 2021.
  • Carisma Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$8.55M, a 59.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$66.8M -$13.1M +$9.2M +41.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$76M -$11.7M +$9.3M +44.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$85.3M -$19.5M +$3.46M +15.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$88.7M -$22.5M -$7.13M -46.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$81.6M -$22.3M -$5.59M -33.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$76M -$21M -$7.03M -50.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$69M -$23M -$12.8M -126% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$56.2M -$15.3M -$24.3M -271% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$31.9M -$16.8M -$79.9M -127% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $48M -$13.9M +$11.5M +45.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $36.5M -$10.2M +$45.1M +81.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$8.55M $8.96M +$23.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$32.1M $63.1M +$84.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$117M -$25.4M +$961K +3.65% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-25
Q1 2021 -$118M -$55.2M -$96.6M -233% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$21.1M -$14.6M +$19.1M +56.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$40.2M -$21.5M -$8.02M -59.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$32.2M -$26.4M +$28.2M +51.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$60.4M $41.4M +$48.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$108M -$33.7M -$26.7M -377% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$81.8M -$13.5M +$946K +6.57% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$82.8M -$54.6M -$45.5M -504% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$37.2M -$6.74M -$2.73M -68.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$34.5M -$7.07M -$473K -7.17% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$34M -$14.4M -$5.25M -57.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$28.8M -$9.03M -$1.68M -22.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$27.1M -$4.01M +$2.16M +35% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$29.3M -$6.59M -$2.97M -82% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$26.3M -$9.15M -$28.7M -147% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 $2.4M -$7.35M -$858K -13.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 $3.25M -$6.16M +$388K +5.92% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 $2.87M -$3.62M +$6.22M +63.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$3.35M $19.5M +$28.9M Jul 1, 2016 Sep 30, 2016 10-K 2018-04-02
Q2 2016 -$32.2M -$6.49M +$1.91M +22.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-02
Q1 2016 -$34.1M -$6.55M +$1.05M +13.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2015 -$35.2M -$9.84M -$2.74M -38.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$32.5M -$9.36M +$1.24M +11.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-24
Q2 2015 -$33.7M -$8.4M -$357K -4.44% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-24
Q1 2015 -$33.3M -$7.6M -$408K -5.68% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-24
Q4 2014 -$32.9M -$7.1M -$2.98M -72.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$30M -$10.6M -$7.06M -199% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-25
Q2 2014 -$22.9M -$8.05M -$4.66M -138% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-25
Q1 2014 -$18.2M -$7.19M -$1.75M -32.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-25
Q4 2013 -$16.5M -$4.12M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-06
Q3 2013 -$3.54M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-06
Q2 2013 -$3.38M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-06
Q1 2013 -$5.44M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.